NCT04519372

SARS-CoV-2 /COVID-19 Admission Screening in a University Hospital Setting

SARS-CoV-2 /COVID-19 Admission Screening in a University Hospital Setting (Covid-Screen Quality Control Study)

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 4,099 (actual)
• Sponsor: University Hospital, Basel, Switzerland · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The proportion of asymptomatic carriers of SARS-CoV-2 remains elusive, so the potential benefit of systematic screening during the SARS-CoV-2-pandemic is controversial. We investigate the proportion of asymptomatic inpatients who were identified by systematic screening for SARS-CoV-2 upon hospital admission. Adult patients admitted to the University Hospital Basel from 01.04.-14.06.2020 were routinely tested for SARS-CoV-2 within 72 hours of admission by nasopharyngeal swabs. Each patient screened during the study period was retrospectively classified symptomatic or asymptomatic for COVID-19 based on medical chart review.

Conditions

• Covid19
• SARS-CoV-2

Interventions

Type	Name	Description
DIAGNOSTIC_TEST	Testing for SARS-CoV-2	All Patients admitted to the hospital were routinely tested for SARS-CoV-2 within 72 hours of admission by nasopharyngeal swabs.

Timeline

• Start date: 2020-04-01
• Primary completion: 2020-06-14
• Completion: 2021-03-31
• First posted: 2020-08-19
• Last updated: 2021-05-18

Locations

1 site across 1 country: Switzerland